Structure Therapeutics Inc

Structure Therapeutics Inc. is a clinical-stage biopharmaceutical company developing innovative oral small molecule therapeutics to treat metabolic, cardiovascular, and pulmonary diseases.

Structure Therapeutics Inc., a clinical-stage biopharmaceutical company, faces significant challenges as it navigates the complex landscape of developing innovative oral small molecule therapeutics for metabolic, cardiovascular, and pulmonary diseas…

Structure Therapeutics Inc. has seen a significant increase in its stock price, rising from a 52-week low of $13.22 to $25.33, driven by its focus on GPCR research and innovative therapeutics.